Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $3.8000 (0.13%) ($3.7900 - $3.8000) on Thu. Jan. 20, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.57% (three month average) | RSI | 33 | Latest Price | $3.8000(0.13%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -1% a day on average for past five trading days. | Weekly Trend | CGEN declines -6.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(86%) ARKK(82%) ARKG(81%) IWO(81%) IBUY(80%) | Factors Impacting CGEN price | CGEN will decline at least -2.285% in a week (0% probabilities). VIXM(-72%) VXX(-52%) UUP(-23%) UNG(-15%) TLT(-4%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.285% (StdDev 4.57%) | Hourly BBV | -0.5 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-7.34(-293.16%) | Resistance Level | $4.17 | 5 Day Moving Average | $3.82(-0.52%) | 10 Day Moving Average | $3.98(-4.52%) | 20 Day Moving Average | $4.17(-8.87%) | To recent high | -47% | To recent low | 0.1% | Market Cap | $314m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |